Summary & Overview
CPT 77771: Multi-Channel Brachytherapy, Interstitial or Intracavitary
CPT code 77771 represents multi-channel brachytherapy—placement of catheters loaded with high-energy radioactive material either within tumors (interstitial) or within body cavities (intracavitary), using two to 12 channels. This procedure is a key localized radiation therapy option for certain malignancies because it allows high-dose delivery to tumor tissue while limiting radiation exposure to surrounding structures. Nationally, accurate coding and dose calculation documentation are important for clinical quality, billing transparency, and payer adjudication.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the code’s clinical intent and service context, common modifiers associated with procedural billing, and what typical sites of service look like for these procedures. The summary also outlines where to expect variation in coverage and documentation practices across major payers and highlights the clinical and billing elements that influence authorization and payment. Data not available in the input are noted where applicable, and the publication focuses on national implications rather than state-specific rules.
Billing Code Overview
CPT code 77771 describes a brachytherapy procedure in which a provider places one or more catheters loaded with a high-energy radioactive substance either directly within cancerous tissue (interstitial) or within a body cavity (intracavitary). The code covers use of two to 12 channels and includes the calculation of the radioactive dose prior to loading the catheter when that calculation is performed.
-
Service type: Internal radiation therapy (brachytherapy) using multi-channel catheters
-
Typical site of service: Hospital outpatient department, ambulatory surgery center, or specialized radiation oncology clinic
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a localized gynecologic or soft-tissue malignancy referred for high-dose-rate (HDR) brachytherapy. The patient presents after initial staging and multidisciplinary tumor board review that recommended localized radiation delivered via intracavitary (e.g., cervical cancer) or interstitial (e.g., head and neck, soft-tissue, or sarcoma) catheter placement. Pre-procedure imaging and treatment planning occur in radiation oncology; informed consent is obtained. Under appropriate anesthesia or sedation in an operating room or procedure suite, the radiation oncologist places two to 12 catheters or applicator channels into the tumor volume or body cavity. The team performs treatment planning calculations (dose calculation, dwell times, source loading) and may perform imaging (CT/MRI) for plan verification. After source loading, the radioactive source is delivered via the implanted channels per the prescribed fractionation; source removal and post-procedure monitoring follow. Typical sites of service are the hospital outpatient department, ambulatory surgery center, or radiation oncology department with access to HDR afterloader equipment and medical physics support. Relevant providers include radiation oncologists, medical physicists, brachytherapy nurses, and anesthesiology when anesthesia is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing separately for the physician’s interpretation/planning distinct from technical services |